Vanta Bioscience Ltd
BSE:540729

Watchlist Manager
Vanta Bioscience Ltd Logo
Vanta Bioscience Ltd
BSE:540729
Watchlist
Price: 15.2 INR 0.33% Market Closed
Market Cap: ₹108.1m

Multiples-Based Value

540729 doesn't have a meaningful market cap.

The Multiples-Based Value of one VANTABIO stock under the Base Case scenario is 12.08 INR. Compared to the current market price of 15.2 INR, Vanta Bioscience Ltd is Overvalued by 21%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VANTABIO Multiples-Based Value
Base Case
12.08 INR
Overvaluation 21%
Multiples-Based Value
Price ₹15.2
Worst Case
Base Case
Best Case

Multiples Across Competitors

VANTABIO Competitors Multiples
Vanta Bioscience Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Vanta Bioscience Ltd
BSE:540729
108.1m INR 8.8 -2.4 -7.9 -4.4
US
PerkinElmer Inc
LSE:0KHE
956.9B USD 335.1 3 967.4 1 136.9 2 189.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
184.2B USD 4.3 28.3 19.6 26.3
US
Danaher Corp
NYSE:DHR
135B USD 5.6 38.4 19.5 28.3
KR
Samsung Biologics Co Ltd
KRX:207940
82.3T KRW 18.1 46.1 30.1 39.4
CN
WuXi AppTec Co Ltd
SSE:603259
302.3B CNY 6.6 15.8 16.5 16.5
CH
Lonza Group AG
SIX:LONN
34.5B CHF 5.4 37 27.5 27.5
US
Agilent Technologies Inc
NYSE:A
32.2B USD 4.7 25.6 18.8 22.2
US
Waters Corp
NYSE:WAT
30.2B USD 9.9 48.8 31.5 39.6
US
IQVIA Holdings Inc
NYSE:IQV
28.9B USD 1.8 21.6 12 18
US
Mettler-Toledo International Inc
NYSE:MTD
25.9B USD 6.7 31 23 25.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Vanta Bioscience Ltd
BSE:540729
Average EV/EBITDA: 133.5
Negative Multiple: -7.9
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 136.9
9%
126.3
US
Thermo Fisher Scientific Inc
NYSE:TMO
19.6
9%
2.2
US
Danaher Corp
NYSE:DHR
19.5
7%
2.8
KR
Samsung Biologics Co Ltd
KRX:207940
30.1
15%
2
CN
WuXi AppTec Co Ltd
SSE:603259
16.5
N/A N/A
CH
Lonza Group AG
SIX:LONN
27.5
31%
0.9
US
Agilent Technologies Inc
NYSE:A
18.8
12%
1.6
US
Waters Corp
NYSE:WAT
31.5
34%
0.9
US
IQVIA Holdings Inc
NYSE:IQV
12
10%
1.2
US
Mettler-Toledo International Inc
NYSE:MTD
23
7%
3.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Vanta Bioscience Ltd
BSE:540729
Average EV/EBIT: 243.2
Negative Multiple: -4.4
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
2 189.2
30%
73
US
Thermo Fisher Scientific Inc
NYSE:TMO
26.3
16%
1.6
US
Danaher Corp
NYSE:DHR
28.3
17%
1.7
KR
Samsung Biologics Co Ltd
KRX:207940
39.4
19%
2.1
CN
WuXi AppTec Co Ltd
SSE:603259
16.5
N/A N/A
CH
Lonza Group AG
SIX:LONN
27.5
17%
1.6
US
Agilent Technologies Inc
NYSE:A
22.2
19%
1.2
US
Waters Corp
NYSE:WAT
39.6
39%
1
US
IQVIA Holdings Inc
NYSE:IQV
18
N/A N/A
US
Mettler-Toledo International Inc
NYSE:MTD
25.5
8%
3.2
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett